J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
J&J seeks FDA approval for new SC injection option for Tremfya in UC treatment. Phase III study shows positive results for symptom relief and colon healing. If approved, it would provide patients with a choice between SC and IV induction.